14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CLRB stock ended at $3.29. This is 1.20% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 5.35% from a day low at $3.18 to a day high of $3.35.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jan 26, 2021 $1.92 $1.93 $1.82 $1.86 1 789 075
Jan 25, 2021 $1.94 $1.96 $1.88 $1.91 1 805 791
Jan 22, 2021 $1.94 $2.03 $1.76 $1.94 2 066 772
Jan 21, 2021 $1.98 $2.00 $1.90 $1.94 1 458 568
Jan 20, 2021 $1.96 $2.05 $1.90 $1.94 2 205 085
Jan 19, 2021 $2.05 $2.05 $1.93 $1.96 2 167 030
Jan 15, 2021 $2.07 $2.09 $1.99 $2.02 1 310 310
Jan 14, 2021 $2.03 $2.08 $1.99 $2.05 1 439 921
Jan 13, 2021 $2.02 $2.09 $1.96 $2.01 1 408 994
Jan 12, 2021 $2.06 $2.10 $1.95 $2.02 1 800 614
Jan 11, 2021 $1.90 $2.10 $1.90 $1.98 2 024 083
Jan 08, 2021 $1.93 $1.96 $1.87 $1.90 1 391 769
Jan 07, 2021 $1.95 $2.00 $1.88 $1.94 2 073 934
Jan 06, 2021 $1.99 $2.02 $1.91 $1.94 1 557 065
Jan 05, 2021 $2.04 $2.07 $1.96 $1.97 2 471 703
Jan 04, 2021 $2.09 $2.09 $2.00 $2.07 1 350 658
Dec 31, 2020 $2.09 $2.12 $2.05 $2.08 880 112
Dec 30, 2020 $2.13 $2.15 $2.07 $2.15 1 096 397
Dec 29, 2020 $2.23 $2.23 $2.01 $2.17 2 198 656
Dec 28, 2020 $2.24 $2.31 $2.00 $2.07 3 621 095
Dec 24, 2020 $2.09 $2.25 $1.99 $2.20 3 258 498
Dec 23, 2020 $1.81 $2.19 $1.80 $2.05 13 148 058
Dec 22, 2020 $2.61 $2.95 $2.56 $2.77 2 800 858
Dec 21, 2020 $2.30 $2.87 $2.30 $2.66 6 319 458
Dec 18, 2020 $2.14 $2.30 $2.06 $2.27 2 259 921
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT